GREGORY L WEAVER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY L WEAVER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY L WEAVER. GREGORY L WEAVER is Chief Financial Officer in Marina Biotech, Inc. ($MRNA) and Director in Celsion CORP ($CLSN) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Chief Financial Officer in Eloxx Pharmaceuticals, Inc. ($SVON) and Director in ATOSSA GENETICS INC ($ATOS) and Director in Egalet Corp ($EGLT).
Latest Insider Trading Transactions of GREGORY L WEAVER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, ATOS, CLSN, ELOX, EGLT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | ATOS | ATOSSA THERAPEUTIC ... | WEAVER GREGORY L | Director | Option Exercise | A | 2.90 | 50,000 | 145,000 | 50,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | WEAVER GREGORY L | Director | Option Exercise | A | 1.70 | 70,000 | 119,000 | 70,000 | |
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | ||
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Payment of Exercise | F | 2.85 | 1,086 | 3,095 | 10,431 | 11.5 K to 10.4 K (-9.43 %) | |
| Mar 16 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Buy | M | 0.00 | 3,750 | 0 | 11,517 | 7.8 K to 11.5 K (+48.28 %) | |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Payment of Exercise | F | 3.91 | 1,733 | 6,776 | 7,767 | 9.5 K to 7.8 K (-18.24 %) |
| Jan 31 2020 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 5,000 | 0 | 9,500 | 4.5 K to 9.5 K (+111.11 %) |
| May 21 2019 | ATOS | ATOSSA GENETICS IN ... | WEAVER GREGORY L | Director | Option Exercise | A | 2.52 | 45,000 | 113,400 | 45,000 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 2.38 | 58,133 | 138,357 | 0 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 4.98 | 29,666 | 147,737 | 0 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 12.08 | 10,000 | 120,800 | 0 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 5.70 | 20,000 | 114,000 | 0 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 15.00 | 667 | 10,005 | 0 | |
| Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 12.00 | 2,083 | 24,996 | 0 | |
| Jan 31 2019 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 31 2019 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | CHIEF FINANCIAL OFF ... | Option Exercise | A | 11.53 | 60,000 | 691,800 | 60,000 | |
| Jun 29 2018 | ATOS | ATOSSA GENETICS IN ... | WEAVER GREGORY L | Director | Option Exercise | A | 2.38 | 45,000 | 107,100 | 45,000 | |
| Mar 26 2018 | ELOX | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Chief Financial Off ... | Buy | P | 8.56 | 4,500 | 38,520 | 4,500 | 0 to 4.5 K |
| Dec 22 2017 | SVON | Eloxx Pharmaceutic ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 7.00 | 399,266 | 2,794,862 | 399,266 | |
| Jun 12 2017 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | A | 2.38 | 58,133 | 138,357 | 58,133 | |
| May 26 2017 | ATOS | ATOSSA GENETICS IN ... | WEAVER GREGORY L | Director | Option Exercise | A | 0.47 | 54,949 | 25,826 | 69,917 | |
| Jun 17 2016 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | A | 4.98 | 29,666 | 147,737 | 29,666 | |
| Jun 17 2016 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | A | 12.08 | 10,000 | 120,800 | 10,000 | |
| May 19 2016 | ATOS | ATOSSA GENETICS IN ... | WEAVER GREGORY L | Director | Option Exercise | A | 0.26 | 112,190 | 29,506 | 112,190 | |
| May 14 2015 | ATOS | ATOSSA GENETICS IN ... | WEAVER GREGORY L | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Mar 26 2007 | CLSN | Celsion CORP | WEAVER GREGORY L | Director | Option Exercise | A | 4.16 | 25,000 | 104,000 | 32,010 | |
| Feb 27 2007 | CLSN | Celsion CORP | WEAVER GREGORY L | Director | Buy | P | 3.50 | 10,000 | 35,000 | 10,000 | 0 to 10 K |
| Mar 16 2006 | CLSN | Celsion CORP | WEAVER GREGORY L | Director | Option Exercise | A | 4.08 | 3,676 | 14,998 | 7,010 | |
| May 27 2005 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 11.54 | 7,500 | 86,550 | 165,000 | |
| May 27 2005 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 16,000 | 8.5 K to 16 K (+88.24 %) |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 11.24 | 7,500 | 84,300 | 90,834 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 8,500 | 1,000 to 8.5 K (+750.00 %) |
Page: 1